Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YF476 in Patients With Chronic Atrophic Gastritis and Type I Gastric Carcinoids
NCT01444014Phase 2Terminated
- Sponsor
- Trio Medicines Ltd
- Start
- Jun 2011
- Primary completion
- May 2012
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of netazepide in gastric carcinoid tumor, sponsored by Trio Medicines Ltd. Started Jun 2011; status: terminated.
02
Drugs
netazepide
03
Conditions
gastric carcinoid tumor
Beyond the preview
Go deeper on NCT01444014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444014.